# EPB41

## Overview
The EPB41 gene encodes the erythrocyte membrane protein band 4.1R, a critical component of the cytoskeletal network in red blood cells. This protein functions as a membrane-cytoskeleton cross-linker, playing a pivotal role in maintaining the structural integrity and mechanical stability of erythrocytes. Protein 4.1R is characterized by several functional domains, including the FERM domain, which facilitates interactions with various membrane proteins and phospholipids, and the spectrin-actin binding domain, which enhances the linkage between spectrin and actin filaments. These interactions are essential for the deformability and resilience of red blood cells as they circulate through the vascular system (Liu2024Cytoskeletal; Baines2010The). The gene undergoes extensive alternative splicing, resulting in multiple isoforms that contribute to its diverse functional roles in cellular processes such as signal transduction and cell adhesion (Liu2024Cytoskeletal). Mutations in EPB41 are associated with hereditary elliptocytosis, underscoring its clinical significance in red blood cell disorders (Marchesi1990Molecular; Conboy1993An).

## Structure
The EPB41 gene encodes the protein 4.1R, a crucial component of the erythrocyte membrane skeleton. Protein 4.1R is composed of several key domains, including the FERM domain, the spectrin-actin binding domain (SABD), and the carboxy-terminal domain (CTD) (Parra2004Differential). The FERM domain, located at the N-terminal, is a globular membrane-binding domain that consists of three lobes with distinct ligand-binding capabilities. It is highly conserved, with about 98% identity between human and mouse orthologs, and is involved in interactions with various proteins in erythroid and non-erythroid cells (Liu2024Cytoskeletal; Baines2014The).

The SABD strengthens the interaction between spectrin and actin and also binds to tropomyosin and myosin (Liu2024Cytoskeletal). The CTD binds to the immunophilin FKBP13 and the nuclear mitotic apparatus (NuMA) (Liu2024Cytoskeletal). Protein 4.1R undergoes extensive alternative splicing, resulting in multiple isoforms ranging from 30 to 210 kDa, with the two most abundant isoforms being 135 kDa and 80 kDa (Liu2024Cytoskeletal). Post-translational modifications, such as phosphorylation, regulate the interactions of the FERM and SAB domains (Liu2024Cytoskeletal). The protein's structure is influenced by differential splicing, affecting its molecular mass and functional properties (Baines2014The).

## Function
The EPB41 gene encodes the erythrocyte membrane protein band 4.1R, which is essential for maintaining the structural integrity and mechanical stability of red blood cells. Protein 4.1R functions as a membrane-cytoskeleton cross-linker, facilitating the binding between spectrin and actin, which are critical components of the erythrocyte membrane skeleton (Liu2024Cytoskeletal; Baines2010The). This interaction is crucial for the formation of a stable and deformable membrane, allowing erythrocytes to withstand the mechanical stress of circulation (Huang2017Circulating).

Protein 4.1R contains several functional domains, including the FERM domain, which binds various membrane proteins and phospholipids, contributing to the structural organization of the cell membrane (Baines2014The). The spectrin-actin binding domain enhances the interaction between spectrin and actin, further supporting membrane stability (Liu2024Cytoskeletal). In erythroid cells, the inclusion of exon 16 in EPB41 transcripts results in isoforms with high affinity for spectrin and actin, which is vital for membrane mechanical stability (Parra2004Differential).

The protein is active in the cell membrane, playing roles in cellular processes such as signal transduction and cell adhesion, which are essential for the proper mechanical properties and stability of erythrocytes (Liu2024Cytoskeletal).

## Clinical Significance
Mutations in the EPB41 gene, which encodes erythrocyte membrane protein band 4.1, are associated with hereditary elliptocytosis (HE), a condition characterized by abnormally shaped red blood cells and hemolytic anemia. These mutations can lead to deficiencies or structural alterations in protein 4.1, affecting the mechanical stability and deformability of erythrocyte membranes (Marchesi1990Molecular; Conboy1993An). Specific mutations, such as a 318-nucleotide deletion, result in the absence of the 80-kD isoform of protein 4.1 in erythrocytes, causing severe hemolytic anemia while sparing nonerythroid cells (Conboy1993An).

In some cases, mutations in EPB41 lead to a complete deficiency of protein 4.1, resulting in severe forms of HE that may require interventions like splenectomy to manage symptoms (Lacy2016Exome). The gene is also implicated in myelodysplastic syndrome (MDS) with elliptocytosis, where abnormal band 4.1 protein levels contribute to erythrocyte shape changes and membrane instability (Ideguchi1993Abnormal). Additionally, EPB41 mutations can cause frameshift mutations leading to truncated proteins, as observed in a Chinese family with HE (Cao2021Clinical). These genetic alterations highlight the critical role of EPB41 in maintaining erythrocyte integrity and its clinical significance in red blood cell disorders.

## Interactions
The EPB41 gene encodes protein 4.1R, which is integral to the erythrocyte membrane skeleton. Protein 4.1R interacts with several membrane-associated proteins, playing a crucial role in maintaining red blood cell morphology and mechanical properties. It facilitates the binding between spectrin and actin, essential for the structural integrity of the cytoskeleton (Liu2024Cytoskeletal; Mohandas2000Protein4.1Rcoredomainstructureandinsightsintoregulationofcytoskeletalorganization).

The protein 4.1R core domain has specific binding sites for various proteins, including band 3, glycophorin C/D, and p55. The band 3 binding motif is located in the N-lobe, while the glycophorin C binding region is within residues 120-166, forming a connecting loop and an α-helix. The p55 binding region is located within residues 214-246 of the C-lobe (Mohandas2000Protein4.1Rcoredomainstructureandinsightsintoregulationofcytoskeletalorganization).

Protein 4.1R also interacts with calmodulin (CaM) through two binding regions, one of which is Ca2+ insensitive. These interactions are crucial for regulating the protein's binding to membrane and skeletal proteins, thereby influencing cell shape and cytoskeletal organization (Mohandas2000Protein4.1Rcoredomainstructureandinsightsintoregulationofcytoskeletalorganization). The N-terminal membrane binding domain of 4.1R interacts with various proteins, including band 3, the rhesus complex proteins, and glycophorin C (Liu2024Cytoskeletal).


## References


[1. (Baines2010The) Anthony J. Baines. The spectrin–ankyrin–4.1–adducin membrane skeleton: adapting eukaryotic cells to the demands of animal life. Protoplasma, 244(1–4):99–131, July 2010. URL: http://dx.doi.org/10.1007/s00709-010-0181-1, doi:10.1007/s00709-010-0181-1. This article has 89 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00709-010-0181-1)

[2. (Marchesi1990Molecular) S L Marchesi, J Conboy, P Agre, J T Letsinger, V T Marchesi, D W Speicher, and N Mohandas. Molecular analysis of insertion/deletion mutations in protein 4.1 in elliptocytosis. i. biochemical identification of rearrangements in the spectrin/actin binding domain and functional characterizations. Journal of Clinical Investigation, 86(2):516–523, August 1990. URL: http://dx.doi.org/10.1172/jci114738, doi:10.1172/jci114738. This article has 22 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci114738)

[3. (Liu2024Cytoskeletal) Jiaojiao Liu, Cong Ding, Xin Liu, and Qiaozhen Kang. Cytoskeletal protein 4.1r in health and diseases. Biomolecules, 14(2):214, February 2024. URL: http://dx.doi.org/10.3390/biom14020214, doi:10.3390/biom14020214. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom14020214)

[4. (Cao2021Clinical) Manxiong Cao, Zhanqin Huang, Huanbing Zhou, Jinghua Lin, and Dongqing Zhang. Clinical and molecular genetic analysis of a chinese family with hereditary elliptocytosis caused by a novel mutation in the epb41 gene. Journal of Clinical Laboratory Analysis, May 2021. URL: http://dx.doi.org/10.1002/jcla.23781, doi:10.1002/jcla.23781. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcla.23781)

[5. (Conboy1993An) J G Conboy, J A Chasis, R Winardi, G Tchernia, Y W Kan, and N Mohandas. An isoform-specific mutation in the protein 4.1 gene results in hereditary elliptocytosis and complete deficiency of protein 4.1 in erythrocytes but not in nonerythroid cells. Journal of Clinical Investigation, 91(1):77–82, January 1993. URL: http://dx.doi.org/10.1172/jci116203, doi:10.1172/jci116203. This article has 31 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci116203)

[6. (Baines2014The) Anthony J. Baines, Hui-Chun Lu, and Pauline M. Bennett. The protein 4.1 family: hub proteins in animals for organizing membrane proteins. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1838(2):605–619, February 2014. URL: http://dx.doi.org/10.1016/j.bbamem.2013.05.030, doi:10.1016/j.bbamem.2013.05.030. This article has 115 citations.](https://doi.org/10.1016/j.bbamem.2013.05.030)

[7. (Mohandas2000Protein4.1Rcoredomainstructureandinsightsintoregulationofcytoskeletalorganization) Narla Mohandas, Bing K. Jap, Bong-Gyoon Han, Wataru Nunomura, and Yuichi Takakuwa. Protein 4.1 r core domain structure and insights into regulation of cytoskeletal organization. Nature Structural Biology, 7(10):871–875, October 2000. URL: http://dx.doi.org/10.1038/82819, doi:10.1038/82819. This article has 150 citations.](https://doi.org/10.1038/82819)

[8. (Huang2017Circulating) Yu-Shan Huang, Luis F. Delgadillo, Kathryn H. Cyr, Paul D. Kingsley, Xiuli An, Kathleen E. McGrath, Narla Mohandas, John G. Conboy, Richard E. Waugh, Jiandi Wan, and James Palis. Circulating primitive erythroblasts establish a functional, protein 4.1r-dependent cytoskeletal network prior to enucleating. Scientific Reports, July 2017. URL: http://dx.doi.org/10.1038/s41598-017-05498-4, doi:10.1038/s41598-017-05498-4. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-05498-4)

[9. (Ideguchi1993Abnormal) Hiroshi Ideguchi, Yumiko Yamada, Seiji Kondo, Kazuo Tamura, Shigeyoshi Makino, and Naotaka Hamasaki. Abnormal erythrocyte band 4.1 protein in myelodysplastic syndrome with elliptocytosis. British Journal of Haematology, 85(2):387–392, October 1993. URL: http://dx.doi.org/10.1111/j.1365-2141.1993.tb03183.x, doi:10.1111/j.1365-2141.1993.tb03183.x. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/j.1365-2141.1993.tb03183.x)

[10. (Lacy2016Exome) Jessica N. Lacy, Jacob C. Ulirsch, Rachael F. Grace, Meghan C. Towne, John Hale, Narla Mohandas, Samuel E. Lux, Pankaj B. Agrawal, and Vijay G. Sankaran. Exome sequencing results in successful diagnosis and treatment of a severe congenital anemia. Molecular Case Studies, 2(4):a000885, March 2016. URL: http://dx.doi.org/10.1101/mcs.a000885, doi:10.1101/mcs.a000885. This article has 8 citations.](https://doi.org/10.1101/mcs.a000885)

[11. (Parra2004Differential) Marilyn Parra, Sherry Gee, Nadine Chan, Dmitriy Ryaboy, Inna Dubchak, Narla Mohandas, Philippe D. Gascard, and John G. Conboy. Differential domain evolution and complex rna processing in a family of paralogous epb41 (protein 4.1) genes facilitate expression of diverse tissue-specific isoforms. Genomics, 84(4):637–646, October 2004. URL: http://dx.doi.org/10.1016/j.ygeno.2004.06.004, doi:10.1016/j.ygeno.2004.06.004. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ygeno.2004.06.004)